Bisphosphonates, osteonecrosis of the jaw, and pharmacovigilance

New Zealand Medical Journal

Volumn 119, Issue 1246, 2006, Pages

  Doogue, Matthew P ^a  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; DIETHYLENE GLYCOL; PAMIDRONIC ACID; PROSTAGLANDIN SYNTHASE INHIBITOR; ROFECOXIB; STEROID; SULFANILAMIDE; THALIDOMIDE; ZOLEDRONIC ACID;

BONE NECROSIS; CANCER PREVENTION; CARDIOVASCULAR DISEASE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; DENTAL CARE; DOSE RESPONSE; DRUG LEGISLATION; DRUG MEGADOSE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG USE; EDITORIAL; FOOD AND DRUG ADMINISTRATION; HEALTH PRACTITIONER; HUMAN; JAW DISEASE; JAW FRACTURE; LONG TERM CARE; MORTALITY; MOUTH EXAMINATION; OSTEOPOROSIS; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY PREVENTION; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; TREATMENT DURATION; TREATMENT REFUSAL; CHEMICALLY INDUCED DISORDER; FEMALE; LEGAL ASPECT; NEW ZEALAND; NOTE; ORGANIZATION AND MANAGEMENT; UNITED STATES;

ADVERSE DRUG REACTION REPORTING SYSTEMS; DIPHOSPHONATES; FEMALE; HUMANS; JAW DISEASES; NEW ZEALAND; OSTEONECROSIS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 33845372119     PISSN: None     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Editorial

References (8)

1. Bolland M, Hay D, Grey A, et al. Osteonecrosis of the jaw and bisphosphonates - putting the risk in perspective [viewpoint article]. N Z Med J. 2006;119(1246). URL: http://www.nzma.org.nz/journal/119-1246/ 2339
2. Nase JB, Suzuki JB. Osteonecrosis of the jaw and oral bisphosphonate treatment. J Am Dent Assoc. 2006;137:1115-9. URL: http://www.ada.org/ prof/resources/topics/osteonecrosis.asp
3. NHS National Library for Health. Prodigy Guidance: Osteoporosis-treatment (and prevention of fragility fractures). Newcastle upon Tyne, UK: NHS National Library for Health. URL: http://www.prodigy.nhs.uk/osteoporosis_treatment/view_whole_guidance
4. Battley J, Jayathissa S, Seneviratne E. Jaw osteonecrosis associated with bisphosphonates [case report]. N Z Med J. 2006;119(1246). URL: http://www.nzma.org.nz/journal/119-1246/2341
5. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-45
6. McBride WG. Thalidomide and congenital abnormalities. Lancet 1961;ii:1358. URL: http://www.jameslindlibrary.org/trial_records/ 20th_Century/1960s/mcbride/mcbride_whole.html
7. De Angelis C, Drazen J, Frizelle F, et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. N Z Med J. 2004;117(1201). URL: http://www.nzma.org.nz/journal/117-1201/ 1054/
8. Consultation Paper. Product Vigilance in the Australia New Zealand Therapeutic Products Authority (ANZTPA); September 2006. URL: http://www.anztpa.org/consult/dr-vigilance.pdf